Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 174

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 174
---
 in order for the safe harbor to be available to the purchaser. The Sponsor and NorthView’s officers, directors and/or their affiliates will not make any such purchases of shares of NorthView Common Stock if the purchases would violate Section 9(a)(2) or Rule 10b -5of the Exchange Act. The Sponsor and NorthView’s executive officers and directors have potential conflicts of interest in recommending that stockholders vote in favor of approval of the Business Combination Proposal and approval of the other proposals described in this proxy statement/prospectus. When you consider the recommendation of NorthView’s Board in favor of approval of Proposal 1 (Business Combination Proposal) and the other proposals you should keep in mind that the Sponsor and certain of NorthView’s directors, officers and initial stockholders have interests in the Business Combination that are different from, or in addition to, your interests as a stockholder. These interests include, among other things: •The Sponsor beneficially owns 4,743,750 founder shares, which shares would become worthless if NorthView does not complete a business combination within the applicable time period, as the NorthView Initial Stockholders have waived any right to redemption with respect to these shares. The Sponsor paid an aggregate of $25,000 (or $0.005 per share) for the 5,175,000 founder shares, 862,500 of which it subsequently forfeited for no consideration. Sponsor subsequently received an additional 431,250 founder shares through a 1.1 -for-1stock dividend. Such shares have an aggregate market value of approximately $[•] million based on the closing price of NorthView Common Stock of $[•] on [•], the Record Date for the special meeting of stockholders. •The Sponsor also beneficially owns 5,162,500 private placement warrants, for which it paid $5,162,500 and which will expire and be worthless if NorthView does not complete a business combination within the applicable time period. •NorthView’s officers and directors have an aggregate of $560,833 invested in the Sponsor, which will be lost in the event that the Business Combination is not approved and concluded. •Certain of NorthView’s officers and directors have invested an aggregate of $115,000 into Profusa’s Bridge Notes, which will be converted into shares of Profusa and exchanged for shares of New Profusa Common Stock in connection with the Merger. •NorthView’s directors will not receive reimbursement for the out -of-pocketexpenses ($22,650 as of